Cognios Beta Neutral Large Cap Fund, LP Pfizer Inc Transaction History

Cognios Beta Neutral Large Cap Fund, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 02, 2024	BUY	$26.13 - $33.94 $19,310 - $25,081	739 Added 4.27%	18,066 $520,000
Q3 2023 Nov 06, 2023	SELL	$32.09 - $37.51 $10,172 - $11,890	-317 Reduced 1.8%	17,327 $574,000
Q2 2023 Aug 03, 2023	SELL	$36.12 - $41.79 $167,921 - $194,281	-4,649 Reduced 20.85%	17,644 $647,000
Q1 2023 May 02, 2023	BUY	$39.39 - $51.28 $59,990 - $78,099	1,523 Added 7.33%	22,293 $909,000
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $208,499 - $272,173	-4,994 Reduced 19.38%	20,770 $1.06 Billion
Q2 2018 Aug 01, 2018	BUY	$32.98 - $35.16 $849,696 - $905,862	25,764 New	25,764 $934,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cognios Beta Neutral Large Cap Fund, LP, based on Form 13F filings with the SEC.

Stay updated on Cognios Beta Neutral Large Cap Fund, LP with notifications on news.